First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 31 January 2011 |
| Author/s |
author: Steven Allen Alan F List |
| Publication date | January 31, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |